Form 4: Oruka Therapeutics Executive Sells Shares
Insider Transaction (Form 4)
Joana Goncalves, Chief Medical Officer of Oruka Therapeutics, Inc., sold 7,000 shares of common stock on July 15, 2026.
Summary
- Option exercise/conversion: acquired 3,500 Common Stock at $6.84 ($23,940) on July 15, 2026; holds 36,218 after (Direct).
- Option exercise/conversion: acquired 3,500 Common Stock at $7.80 ($27,300) on July 15, 2026; holds 39,718 after (Direct).
- Open-market sale: disposed of 400 Common Stock at $84.36 ($33,746) on July 15, 2026; holds 39,318 after (Direct).
- Open-market sale: disposed of 2,497 Common Stock at $85.86 ($214,385) on July 15, 2026; holds 36,821 after (Direct).
- Open-market sale: disposed of 3,803 Common Stock at $86.68 ($329,630) on July 15, 2026; holds 33,018 after (Direct).
- Open-market sale: disposed of 300 Common Stock at $87.25 ($26,176) on July 15, 2026; holds 32,718 after (Direct).
- Option exercise/conversion: disposed of 3,500 Employee Stock Option (right to buy) on July 15, 2026; holds 200,563 after (Direct).
- Option exercise/conversion: disposed of 3,500 Employee Warrant (right to buy) on July 15, 2026; holds 171,992 after (Direct).
Sentiment
Score: 4
Explanation: StockSavvy.ai views this as a mildly negative but low-conviction signal: an insider sold $603,938 of stock under a pre-arranged Rule 10b5-1 plan, which is typically routine.
Insider Transactions
Joana Goncalves — Officer (Chief Medical Officer)
Transaction made under a Rule 10b5-1 trading plan.
| Date | Transaction | Security | Shares | Price | Value | Held After |
|---|---|---|---|---|---|---|
| 2026-07-15 | Option exercise/conversion | Common Stock | 3,500 | $7 | $23.9K | 36,218 |
| 2026-07-15 | Option exercise/conversion | Common Stock | 3,500 | $8 | $27.3K | 39,718 |
| 2026-07-15 | Open-market sale | Common Stock | 400 | $84 | $33.7K | 39,318 |
| 2026-07-15 | Open-market sale | Common Stock | 2,497 | $86 | $214.4K | 36,821 |
| 2026-07-15 | Open-market sale | Common Stock | 3,803 | $87 | $329.6K | 33,018 |
| 2026-07-15 | Open-market sale | Common Stock | 300 | $87 | $26.2K | 32,718 |
| 2026-07-15 | Option exercise/conversion | Employee Stock Option (right to buy) | 3,500 | — | — | 200,563 |
| 2026-07-15 | Option exercise/conversion | Employee Warrant (right to buy) | 3,500 | — | — | 171,992 |
Key Dates
| Date | Description |
|---|---|
| 2026-07-15 | Option exercise/conversion (3,500 shares) |
| 2026-07-15 | Option exercise/conversion (3,500 shares) |
| 2026-07-15 | Open-market sale (400 shares) |
| 2026-07-15 | Open-market sale (2,497 shares) |
| 2026-07-15 | Open-market sale (3,803 shares) |
| 2026-07-15 | Open-market sale (300 shares) |
| 2026-07-15 | Option exercise/conversion (3,500 shares) |
| 2026-07-15 | Option exercise/conversion (3,500 shares) |
Keywords
insider transaction, Form 4, ORKA, Oruka Therapeutics, Inc., bearish, Joana Goncalves
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.